Aptevo Therapeutics Plunges 10.67% on Reverse Stock Split

On May 23, 2025, Aptevo Therapeutics experienced a significant drop of 10.67% in pre-market trading, marking a notable decline in its stock performance.

Aptevo Therapeutics has announced a 1-for-20 reverse stock split, which is set to take effect on May 23, 2025, at 5:01 p.m. Eastern Time. This move is aimed at maintaining the company's compliance with Nasdaq listing standards. The reverse stock split will adjust the number of outstanding shares, potentially impacting the stock's trading dynamics and investor sentiment.

The decision to implement a reverse stock split is a strategic move by Aptevo Therapeutics to address its stock price and market capitalization. This action is often taken by companies to boost their stock price per share, making it more attractive to investors and meeting exchange listing requirements. The reverse stock split is expected to become effective on the specified date, with shares beginning to trade on a split-adjusted basis thereafter.